1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Abnormal DNA Repair: new trials by email Literature Review of Abnormal DNA Repair trials Research Report on Abnormal DNA Repair
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects Olaparib, Abiraterone Acetate, Prednisone - Prostate Cancer Metastatic Castration-Resistant, Abnormal DNA Repair | Phase 2 | Active not recruiting | Northwestern University | 70 | 2017-01-12 | 2026-06-01 |
Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
Abiraterone Acetate (1) · Prednisone (1) · olaparib (1)
United States (1)
Maha Hussain, MD, FACP, FASCO (1)